A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
Status:
RECRUITING
Trial end date:
2026-03-28
Target enrollment:
Participant gender:
Summary
This trial is conducted in Indonesia. The aim of the trial is to evaluate the efficacy and safety of BGM0504 versus semaglutide as add-on to metformin in patients with type 2 diabetes